AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Caribou Biosciences, Inc. Common Stock
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG008G28LH7
0.53▼ 0.03 (-4.86%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.56
Day's Range
0.53 – 0.58
52-Week Range
0.44 – 3.54
Volume
2.1M
Avg Volume
3.9M
Share Statistics
Shares Outstanding
Employees
97
Exchange
XNAS
Listed
2021-07-23
Share count as of August 7, 2026

Caribou Biosciences, Inc. Common Stock (CRBU) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Caribou Biosciences, Inc. Common Stock (CRBU)
What is Caribou Biosciences, Inc. Common Stock's Market Cap?
Caribou Biosciences, Inc. Common Stock's Market Cap is $57.1M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Enterprise Value?
Caribou Biosciences, Inc. Common Stock's Enterprise Value is $30.9M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Price / Sales?
Caribou Biosciences, Inc. Common Stock's Price / Sales is 5.7×, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's EV / Revenue?
Caribou Biosciences, Inc. Common Stock's EV / Revenue is 3.1×, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's EV / EBITDA?
Caribou Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Revenue (TTM)?
Caribou Biosciences, Inc. Common Stock's Revenue (TTM) is $10.0M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Net Income (TTM)?
Caribou Biosciences, Inc. Common Stock's Net Income (TTM) is -$103.4M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's EBITDA?
Caribou Biosciences, Inc. Common Stock's EBITDA is -$106.9M, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's Diluted EPS (TTM)?
Caribou Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -0.96, based on as-reported figures from SEC (XBRL) filings.
What is Caribou Biosciences, Inc. Common Stock's EBITDA Margin?
Caribou Biosciences, Inc. Common Stock's EBITDA Margin is -1065.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CRBUAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue ($ from related party for the three months ended xxx, respectively)
YoY growth-43.8%+1.9%+89.7%+8.6%
Operating expenses:
Research and development
General and administrative
Asset, Impairment Loss—
Total operating expenses
% of revenue1790.4%1196.4%822.0%1437.6%
Loss from operations
% of revenue-1690.4%-1096.4%-722.0%-1337.6%
Other income (expense)
Impairment Of Equity Method Investment—
Other income, net
Total other income (expense)
Net loss
% of revenue-1619.9%-1046.5%-672.1%-1253.3%
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)